Whitbread shares rise 4% as brokers flag stronger trading and upgrade potential

Impact · against what's priced in

Whitbread is seeing a positive catalyst as H2 trading data suggests a move toward the top end of profit guidance, while Arecor's clinical updates remain marginally positive but lack significant scale. The most material impact is the shift in earnings probability for WTB based on recent RevPAR and sales growth.

WTB+0.60

No priced-in read yet

In context

Accommodation sales rising 4.5% and RevPAR increasing 3.2% in the first five weeks of H2 provides concrete evidence that FY profits are likely to hit the top end of the £408 million guidance.

Read from the article alone

• earnings
• AREC
• WTB
• activist investor
• broker rating
• cost savings
• hospitality
• hotels
• profit forecast
• shareholder returns

Search tags